These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37597535)

  • 1. Case Report of Umbilical Artery Thrombosis in a Patient With a History of Heparin-Induced Thrombocytopenia.
    Dindinger R; Mulla BM; Stucky C
    J Obstet Gynecol Neonatal Nurs; 2023 Nov; 52(6):501-508. PubMed ID: 37597535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
    Burger CF; Schlesinger JJ
    Ann Pharmacother; 2014 Feb; 48(2):286-91. PubMed ID: 24259642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expectant management for umbilical artery thrombosis in monochorionic diamniotic twin pregnancies: a case report.
    Wang Q; Zhang Y; Zhou R
    BMC Pregnancy Childbirth; 2023 Jul; 23(1):515. PubMed ID: 37452280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of danaparoid in two pregnant women with heart valve prosthesis and heparin-induced thrombocytopenia Type II (HIT).
    Gerhardt A; Scharf RE; Zotz RB
    Clin Appl Thromb Hemost; 2009; 15(4):461-4. PubMed ID: 18840630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia: natural history, diagnosis, and management.
    Deitcher SR; Carman TL
    Vasc Med; 2001; 6(2):113-9. PubMed ID: 11530963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Linkins LA; Dans AL; Moores LK; Bona R; Davidson BL; Schulman S; Crowther M
    Chest; 2012 Feb; 141(2 Suppl):e495S-e530S. PubMed ID: 22315270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia.
    Ciurzyński M; Jankowski K; Pietrzak B; Mazanowska N; Rzewuska E; Kowalik R; Pruszczyk P
    Med Sci Monit; 2011 May; 17(5):CS56-9. PubMed ID: 21525816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
    Levy JH; Tanaka KA; Hursting MJ
    Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin-induced thrombocytopenia syndrome and thrombosis in patients undergoing periodic haemodialysis].
    Gregorini G; Bellandi D; Martini G; Volpi R
    G Ital Nefrol; 2002; 19(6):672-92. PubMed ID: 12508172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in diagnosis and treatment of heparin-induced thrombocytopenia.
    Lubenow N
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):407-12. PubMed ID: 15692252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.
    Junqueira DR; Zorzela LM; Perini E
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007557. PubMed ID: 28431186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update.
    Favaloro EJ; McCaughan G; Pasalic L
    Pathology; 2017 Jun; 49(4):346-355. PubMed ID: 28446364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia: an uncommon but serious complication of heparin use in renal replacement therapy.
    Charif R; Davenport A
    Hemodial Int; 2006 Jul; 10(3):235-40. PubMed ID: 16805883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia in pediatrics.
    Severin T; Sutor AH
    Semin Thromb Hemost; 2001 Jun; 27(3):293-9. PubMed ID: 11446663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Soini B; Ramon R; Scandellari R; Randi ML; Girolami A
    J Intern Med; 2002 Aug; 252(2):149-54. PubMed ID: 12190890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heparin-induced thrombocytopenia: Update].
    Camoin-Jau L; Mariotti A; Suchon P; Morange PE
    Rev Med Interne; 2022 Jan; 43(1):18-25. PubMed ID: 34535328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of heparin-induced thrombocytopenia.
    Donovan JL; Tran MT; Kanaan AO
    J Pharm Pract; 2010 Jun; 23(3):226-34. PubMed ID: 21507818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of 31 cases of fetal umbilical artery thrombosis].
    Jiang RA; Xu T; Li W; Jin LF; Zhou YM; Bai XX; He J
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jul; 58(7):495-500. PubMed ID: 37474322
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia from venous thromboembolism treatment.
    Begelman SM; Hursting MJ; Aghababian RV; McCollum D
    J Intern Med; 2005 Dec; 258(6):563-72. PubMed ID: 16313480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene.
    Warkentin TE
    J Thromb Haemost; 2018 Nov; 16(11):2128-2132. PubMed ID: 30099843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.